~~<i id='9F64635611'><strike id='9F64635611'><tt id='9F64635611'><pre id='9F64635611'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：Wikipedia 2025-10-02 10:12:02 Page View：25885

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： UnitedHealth’s Optum accused of antitrust violations in California
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

Wikipedia

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

NIH chief: government has fallen behind pharma on clinical trials

NationalInstitutesofHealthDirectorMonicaBertagnollitestifiesduringherSenateHELPCommitteeconfirmation

Anesthesiologist group: stop taking Ozempic before surgery

EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

Publishing genetic code of viruses could cause disaster

HealthworkersatalabinHongKongtestingforcoronavirusinMarch2022.KinCheung/APThewhollysyntheticmRNAvacc